|
See related Human Albumin 20% Behring, Low Salt inj information |
|
|
|
Manufacturer |
CSL Behring |
|
Distributor |
Sanofi Pasteur |
|
Contents |
Human albumin |
|
Indications |
Albumin deficiency. |
|
Dosage |
Individualised dosage. Dilute 4-5% soln for vol replacement. |
|
Contraindications |
Known hypersensitivity to plasma proteins. |
|
Adverse Drug Reactions |
Mild reactions eg skin reddening, urticaria, increase or decrease in BP, fever, nausea & vomiting.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Human Albumin 20% Behring, Low Salt injection |
|
Human Albumin 20% Behring, Low Salt 20 % x 50 mL x 1's |
|
|
|
Manufacturer: |
CSL Behring |
|
Distributor: |
Sanofi Pasteur
|
|
|
|
